Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-response study of daridorexant in insomnia
NCT02839200Phase 2Completed
- Sponsor
- Idorsia
- Start
- Oct 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of daridorexant in insomnia disorder, sponsored by Idorsia. Started Oct 2016; status: completed.
02
Drugs
daridorexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT02839200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02839200.